Nephros Inc SEC filings NEPH
Nephros Inc has 1,005 filings in SEC EDGAR's recent list, going back to Nov 15, 2004. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 14, 2026 | Oct 14, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 12, 2024 | — |
| DEF 14A | Proxy statement | Apr 12, 2024 | Apr 12, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | Apr 21, 2023 |
| DEF 14A | Proxy statement | Apr 13, 2022 | Apr 13, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2021 | — |
| DEFA14A | Additional proxy material | Apr 7, 2021 | — |
| DEF 14A | Proxy statement | Apr 7, 2021 | Apr 7, 2021 |
| DEFA14A | Additional proxy material | May 11, 2020 | — |
| DEF 14A | Proxy statement | Apr 8, 2020 | Apr 8, 2020 |
| DEFA14A | Additional proxy material | Apr 8, 2020 | — |
| DEFA14A | Additional proxy material | May 2, 2019 | — |
| DEF 14A | Proxy statement | Apr 10, 2019 | Apr 10, 2019 |
| DEFA14A | Additional proxy material | Apr 10, 2019 | — |
| DEF 14C | Information statement | Aug 22, 2018 | Aug 22, 2018 |
| PRE 14C | Filing | Aug 8, 2018 | Aug 8, 2018 |
| DEFA14A | Additional proxy material | Apr 11, 2018 | — |
| DEF 14A | Proxy statement | Apr 11, 2018 | Apr 11, 2018 |
| DEF 14A | Proxy statement | Apr 14, 2014 | May 16, 2014 |
| DEF 14A | Proxy statement | Apr 11, 2013 | May 13, 2013 |
| DEF 14A | Proxy statement | Mar 22, 2012 | Apr 23, 2012 |
| DEF 14A | Proxy statement | Dec 2, 2010 | Jan 10, 2011 |
| PRE 14A | Preliminary proxy statement | Oct 1, 2010 | Oct 1, 2010 |
| DEF 14A | Proxy statement | Sep 28, 2009 | Oct 22, 2009 |
| PRE 14A | Preliminary proxy statement | Sep 4, 2009 | Oct 22, 2009 |
| DEF 14A | Proxy statement | Apr 29, 2008 | Jun 25, 2008 |
| DEF 14C | Information statement | Oct 24, 2007 | Oct 23, 2007 |
| PRE 14C | Preliminary information statement | Oct 11, 2007 | Oct 10, 2007 |
| DEFA14A | Additional proxy material | May 24, 2007 | — |
| DEF 14A | Proxy statement | Apr 30, 2007 | May 22, 2007 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2007 | May 22, 2007 |
| DEF 14A | Proxy statement | May 1, 2006 | Jun 21, 2006 |
| DEF 14A | Proxy statement | May 13, 2005 | Jun 23, 2005 |
| PRE 14A | Preliminary proxy statement | May 2, 2005 | Jun 23, 2005 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NEPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South Orange, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1196298
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.